Skip to content
Cytognomix Logo
We find and validate mutations that others cannot
  • Home
  • Mission
    • Challenges in genomics: our solutions
  • Products
    • Biodosimetry: Automated Dicentric Chromosome Identifier
      • Testing for Radiation Exposure
    • Mutation Forecaster®
      • Interpretation of mutations in next generation sequencing data: Shannon pipeline
        • Testimonials for the Shannon pipeline
      • Automated Splice Site and Exon Definition Server (ASSEDA)
        • Publications
      • Software for validation of predicted mRNA splicing mutations
        • Testimonials for Veridical
      • Cytognomix User Variation Database (CUVD)
    • Solution capture pools for targeted deep sequencing
    • Targeted array CGH
    • Single copy FISH
      • Customized scFISH probes
      • Standard SC-FISH probes
      • Subtelomeric SC-FISH probes Catalog
    • Product advantages
    • Product Gallery
  • Posts
  • Purchase
    • Pricing
  • Contact Us
  • About us
    • Intellectual Property
    • Applications
  • Resources
  • SiteMap
  • Menu

ST-0000038

16/AML-M4(Acute Myelogenous leukemia – M4) E3

Gene:

ABCC1/MDR1

Interval:

IVS 6

Cytogenetic nomenclature: ish inv (16)(p13q22)(ABCC1st)

[dpsc_display_product]

Written by: Peter Rogan on August 25, 2009.
Last revised by: May 17, 2011.
Posted in and tagged 16/AML-M4(Acute Myelogenous leukemia - M4) E3 Gene: ABCC1/MDR1.

Post navigation

Map →

Recent Posts

  • January 25, 2024. Appreciation of Cytognomix’s COVID-19 research studies by the government of Ontario
  • Oct. 4, 2023. Radiobiology textbook published
  • Sept. 19, 2023. Democratizing ADCI as cloud-based software
  • May 25, 2023. CytoGnomix to present at final RCP meeting of IAEA CRP E35010 (MEDBIODOSE)
A SiteOrigin Theme